KALA PHARMACEUTICALS INC's ticker is KALA and the CUSIP is 483119103. A total of 109 filers reported holding KALA PHARMACEUTICALS INC in Q2 2021. The put-call ratio across all filers is 0.98 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $41,000 | -68.5% | 29,559 | -72.5% | 0.00% | – |
| Q4 2021 | $130,000 | -44.7% | 107,582 | +208.3% | 0.00% | – |
| Q1 2021 | $235,000 | +6.3% | 34,892 | +7.0% | 0.00% | – |
| Q4 2020 | $221,000 | +16.3% | 32,597 | +28.9% | 0.00% | – |
| Q3 2020 | $190,000 | -89.5% | 25,298 | -85.3% | 0.00% | -100.0% |
| Q2 2020 | $1,807,000 | +190.5% | 171,898 | +143.1% | 0.00% | +100.0% |
| Q1 2020 | $622,000 | +1010.7% | 70,715 | +368.3% | 0.00% | – |
| Q4 2019 | $56,000 | -84.8% | 15,100 | -66.1% | 0.00% | – |
| Q1 2019 | $369,000 | -30.5% | 44,575 | -59.0% | 0.00% | -100.0% |
| Q4 2018 | $531,000 | +147.0% | 108,590 | +398.0% | 0.00% | – |
| Q3 2018 | $215,000 | -53.6% | 21,804 | -25.4% | 0.00% | -100.0% |
| Q1 2018 | $463,000 | – | 29,244 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| CAXTON CORP | 1,430,021 | $9,638,000 | 6.26% |
| RA Capital Management | 10,874,613 | $73,295,000 | 1.10% |
| Mesirow Financial Investment Management, Inc. | 41,961 | $283,000 | 0.77% |
| Samsara BioCapital, LLC | 601,162 | $4,052,000 | 0.75% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 102,198 | $689,000 | 0.38% |
| Eventide Asset Management | 3,450,000 | $23,253,000 | 0.34% |
| Orbimed Advisors | 5,465,030 | $36,834,000 | 0.34% |
| Parkman Healthcare Partners LLC | 148,433 | $1,000,000 | 0.23% |
| Vivo Capital, LLC | 786,883 | $5,304,000 | 0.19% |
| Knights of Columbus Asset Advisors LLC | 199,954 | $1,348,000 | 0.13% |